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Abstract
Self-expandable metallic stents (SEMS) insertion to the oesophagus is the method of choice in palliative treatment of malignant 
oesophago-respiratory fistulas (ERF). ERF evolve as a result of 0.2−5% of advanced oesopghageal or lung cancer. They also 
appear after radiotherapy. EFR are serious and lethal complications. SEMS insertion is an effective, safe, technically simple and 
minimally invasive solution. Potential complications of SEMS include thoracic pain, bleeding, perforation, stent migration, tumour 
overgrowth or ingrowth and food bolus impaction. The article presents three cases of patients with advanced lung cancer with 
EFR subjected to SEMS insertion procedure in our centre.
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Introduction
The oesophago-respiratory fistulas (EFR) are 
formed between the lumen of the oesopghagus 
and bronchus or trachea due to the development 
and proliferation of oesophageal or extraoesoph-
ageal carcinoma. Occasionally, fistulas develop 
between the oesophagus and mediastinum, aorta, 
pleura or tumour cavity. In the group of 1943 
patients with oesophageal cancer, EFR were 
diagnosed in 5% of them, whereas in the group 
of 5714 bronchial cancer patients, EFR were 
found in 0.2% of patients [1]. EFR can develop 
in about 5.8% of patients after radiotherapy [2]. 
The development of oesophageal carcinoma as 
well as proliferation of bronchial cancer into the 
oesophagus cause the symptoms of dysphagia in 
the first instance. The development of EFR seri-
ously impacts patients’ survival, which may be 
limited to weeks [3]. EFR symptoms include choke 
and cough associated with eating and drinking, 
dysphagia and dyspnoea [4]. SEMS implantation 
is an effective, safe and relatively simple method 
of choice in palliative treatment of patients with 
EFR [4−8]. SEMS have been used for ERF since 
the early 1990s, when they replaced rigid plastic 
stents [4, 5]. SEMS insertion effectively closes 
fistulas in 88.9–96% of patients [4, 6, 9−12]. 
In selected cases, endoscopic double stenting 
(airway and esophageal) is performed [13, 14]. 
However, SEMS implantation could lead to 
complications, which occur in 10−30% of cases 
[4, 7, 12]. They may be divided into two groups. 
Early complications, occurring up to 30 days from 
SEMS implantation, include: pain, vomiting, 
bleeding, malposition/migration, perforation and 
dysphagia. Late complications, occurring after 
30 days, comprise: tumour overgrowth and in-
growth, migration, haemorrhage, fistulas, food 
impaction and esophagitis [4, 7, 12]. Stent migra-
tion is a common complication [9]. It may cause 
gastrointestinal tract obstruction [15]. Stents are 
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usually applied in analgosedation under endo-
scopic and/or fluoroscopic control. There are no 
statistical significant differences between these 
two methods [7]. In 95% of patients, SEMS im-
plantation causes immediate improvement and 
enables oral nutrition [4−6, 9, 11, 12]. SEMS 
implantation improves the quality of life and 
increases the lifespan [6, 11, 12]. The successful 
stent placement enables the patient to receive 
palliative chemo- or radiotherapy [13].
Case reports
Case 1
A 58 year-old male suffering from squamous 
cell carcinoma of the mediastinum, after radical 
teleradiotherapy in 2013, brachytherapy in 2014, 
and with metastases to mediastinal and cervical 
lymph nodes, was admitted to the hospital be-
cause of increased dyspnoea, haemoptysis, choke 
and cough during eating and drinking. Diagnostic 
tests including computed tomography of the chest 
revealed oesophago-respiratory fistula, which was 
also confirmed at endoscopic examination of the 
upper gastrointestinal tract. SEMS insertion to 
the oesophagus was performed in analgoseda-
tion under fluoroscopic control. Stent location 
was controlled and corrected under endoscopic 
guidance, dilation of stenosis and fistula complete 
closure were obtained. The placement of the stent 
significantly improved the patient’s symptoms. 
No significant early complications were observed. 
The patient was allowed oral nutrition. He was 
discharged in a good general condition.
Case 2
A 51 year-old male with non-small cell lung 
carcinoma of the left lung was admitted after 
chemo- and radiotherapy due to dysphagia, ody-
nophagia and bad general condition. Computed 
tomography of the chest revealed connection 
between the oesophagus and tumour cavity. The 
tumour infiltrated the parietal pleura, main left 
bronchus, trachea, penetrated the mediastinum 
and infiltrated the oesophagus. The endoscopic 
examination of the upper digestive tract showed 
a big, oval fistula to the tumour cavity, located 
centrally, inside the oesophagus, at a depth of 
22 cm. The constricted lumen of the infiltrated 
oesophagus was located laterally. The steno-
sed segment of the oesophagus was overcome 
with the standard diameter endoscope. The 
SEMS implantation was performed in analgo-
sedation, under fluoroscopic control, along the 
Savary-Gillard guide wire. Endoscopic control 
revealed fistula’s total closure and dilation of 
the oesophageal lumen. The patient’s condition 
improved and the majority of complaints were 
dealt with. No significant early complications 
were observed. The next day, oral nutrition 
was successfully introduced. The patient was 
discharged.
Case 3 
A 73 year-old female with non-small cell 
carcinoma of the right lung was earlier hospi-
talized in our ward due to dysphagia caused by 
oesophagus stenosis induced by the growth of 
the lung tumour. The stenosis was successfully 
widened with the use of endoscope. After one 
month, the patient was readmitted because of 
dysphagia increase, cough and choke associated 
with eating and drinking. Endoscopic examina-
tion of the upper gastrointestinal tract revealed 
stenosis of the oesophagus and fistula to the res-
piratory tract. The stenosis was overcome with the 
endoscope 5.9 mm in diameter. Along the guide, 
under fluoroscopic control, in analgosedation, 
SEMS was inserted. The stent position was con-
trolled under endoscopic guidance. The fistula 
closure and dilation of the stenosed segment of 
the oesophagus were confirmed. No significant 
early complications were observed. The next day, 
oral nutrition was successfully introduced. The 
patient was discharged.
Figure 1. Oesophageal fistula in lateral reconstruction on computed 
tomography of the thoracic cavity
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average time of post implantation hospitalization 
was 3.7 days [3]. 
Balazs et.al described data collected at one 
centre in which, in the years 1984−2004, 264 
cases of ERF were diagnosed. SEMS efficient im-
plantation was achieved in 188 cases. The authors 
reported one lethal complication. In the second 
group of patients, 25 gastrostomies, 1 jejunosto-
my and 1 percutaneous endoscopic gastrostomy 
were made. The average survival time in patients 
after SEMS implantation was 3.4 months. In the 
remaining group it was 1.1 month. The differen-
ces between the two groups were significant [11]. 
Kim et.al. discussed 9 cases of ERF patients: 
6 with oesophageal carcinoma, 2 with lung carci-
noma and 1 with Boerhaave Syndrome. Technical 
success was achieved in 8 cases. In one case, 
unsuccessful ERF closure was strictly connected 
with non-complete stent dilation. Clinical success 
defined as the fistula complete closure within 
7 days was achieved in five patients. Four patients 
were reoperated because of the gap between the 
stent and the oesophagus in 3 patients, and stent 
migration in 1 patient. The average survival time 
after efficient implantation was 78.8 days [12]. 
Herth et al. described 112 ERF patients, 
among whom 83 (74%) presented advanced lung 
carcinoma and 29 (26%) suffered from advanced 
oesophageal carcinoma. The authors implanted 
SEMS to the oesophagus in 37 patients (33%). 
In 65 patients, airway stents were inserted. Both 
airway and oesophageal stents were used in 
10 patients. Seven patients (one with oesophage-
al stent, two with both the oesophageal and the 
airway one, and four with airway stents) deve-
loped respiratory failure and required transient 
ventilator support in the intensive care unit. The 
authors did not observe stents migration. The 
average survival time of patients with oesopha-
geal SEMS implantation was 262.8 days. The 
average quality of life (QoL) score before stents 
implantation was 72, and after the procedure it 
amounted to 81. The difference was statistically 
significant [14]. 
The reported cases were the first ones in our 
centre. We performed the described procedures 
under fluoroscopic and endoscopic control, in 
analgosedation. We did not observe any of signi-
ficant early complications, therefore we confirm 
that SEMS insertion is an effective, safe and rela-
tively easy method, which improves the quality 
of life, positively influences its elongation and 
enables further palliative treatment including 
radiotherapy. We do recommend SEMS implan-
tation.
Figure 2. Oesophago-respiratory fistula — endoscopic image
Figure 3. Endoscopic image after SEMS implantation, successful dila-
tion of the stenosed segment of the oesophagus and the fistula closure
  
Discussion
Wierzbicki et al. [4] described 14 patients 
with EFR caused by carcinoma, in whom 15 SEMS 
were inserted. A good early effect was observed in 
12 of them. In two patients, after several months, 
the authors observed the tumour overgrowth, 
which caused its damage with argon plasma 
coagulation. In two other patients, the authors 
found fistula recurrence, and in one case, retrial 
of a new stent application was possible. The lon-
gest observed survival period was 13 months [4]. 
Turkyilmaz et.al. described 14 cases of pa-
tients in whom, in the years 2003−2008, SEMS 
were implanted due to ERF. Fistula closure was 
achieved in all 14 patients. No significant com-
plications were observed. The mean survival time 
after SEMS implantation was 11.2 weeks. The 
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